14th Dec 2021 19:17
Omega Diagnostics Group PLC - Alva, Scotland-based medical diagnostics company - Technology partner Mologic Ltd announces that data has confirmed that the Mologic Covios Ag lateral flow test can detect the Omicron variant of Covid-19 as it does with existing known variants.
"We are very pleased be in a position to confirm that the VISITECT COVID-19 antigen test is able to equally detect the Omicron variant, as well as other existing variants. We remain encouraged by emerging commercial opportunities for our VISITECT COVID-19 Antigen test that we expect to be unlocked following relevant approval under CTDA regulations and CE-marking for home-use," says Chief Executive Officer Colin King.
Current stock price: 25.50 pence, up 7.4% on Tuesday
Year-to-date change: down 60%
By Dayo Laniyan; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
ODX.L